Janux Therapeutics News

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(4.8%)

Nov 14 17:15 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(2.0%),Citadel Advisors LLC(1.9%), etc.

Nov 14 16:32 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.

Nov 14 16:29 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Nov 12 10:38 ET

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(4.1%),Tighe Reardon(3.0%), etc.

Nov 8 18:00 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila

Nov 7 19:13 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L

Nov 7 19:13 ET

Janux Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:29 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 6 16:15 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bregua Corporation(5.8%)

Nov 4 16:11 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 17:07 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 17:07 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 16:33 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 16:28 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 16:22 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 16:12 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan

Oct 30 19:32 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 28 17:09 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 28 17:05 ET

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 28 16:49 ET